HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hussain, M. M. Articles by Mahley, R. W. Search for Related Content PubMed PubMed Citation Articles by Hussain, M. M. Articles by Mahley, R. W. Social Bookmarking                      What's this?

Volume 270, Number 15, Issue of April 14, pp. 8578-8587, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.

---

M. Mahmood Hussain , Thomas L. Innerarity , Walter J. Brecht , Robert W. Mahley

The plasma clearance of radiolabeled chylomicrons was compared in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic (WHHL) rabbits. Chylomicron clearance was rapid in normal rabbits but was significantly retarded in cholesterol-fed and WHHL rabbits. At 40 min after the injection of chylomicrons, 14-17% of the injected dose remained in the plasma of normal rabbits, whereas 40-50% of the injected dose remained in the plasma of cholesterol-fed and WHHL rabbits. The differences were reflected in the reduced plasma clearance by the liver and bone marrow of the cholesterol-fed and WHHL rabbits. The hyperlipidemic rabbits expressed normal levels of low density lipoprotein (LDL) receptor-related protein/-macroglobulin receptor in the liver. In contrast, the hepatic levels of LDL receptors were lower in hyperlipidemic rabbits; as expected, they were significantly lower in WHHL rabbits compared with normal and cholesterol-fed rabbits. Furthermore, it was demonstrated that lipoproteins accumulating in the plasma of the hyperlipidemic rabbits competed for and retarded the clearance of chylomicrons from the plasma. Competition was demonstrated by cross-circulation of normal and cholesterol-fed or normal and WHHL rabbits, in which the rapid influx of plasma containing the accumulated plasma lipoproteins from cholesterol-fed or WHHL rabbits was shown to impair the uptake of chylomicrons by the liver and bone marrow of normal rabbits. These observations were extended by infusing isolated lipoproteins into normal rabbits. The rabbit d < 1.02 g/ml (remnant) fraction and the canine cholesterol-rich high density lipoproteins (HDL) with apolipoprotein E (HDL) inhibited chylomicron clearance, whereas human LDL and HDL from humans and rabbits did not. We conclude that the low LDL receptor activity in the cholesterol-fed and WHHL rabbits may contribute, at least in part, to the impaired clearance by decreasing remnant uptake and causing the accumulation of chylomicron and/or very low density lipoprotein remnants. The accumulated remnant lipoproteins then compete for and saturate the mechanism responsible for the initial rapid clearance of chylomicrons from the plasma. We speculate that saturation of the initial rapid clearance may occur at the sequestration step, which involves the binding of remnants to heparan sulfate proteoglycans in the space of Disse.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				T. Koike, J. Liang, X. Wang, T. Ichikawa, M. Shiomi, H. Sun, T. Watanabe, G. Liu, and J. Fan Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase Cardiovasc Res, February 1, 2005; 65(2): 524 - 534. [Abstract] [Full Text] [PDF]

				N. Nayak, E. H. Harrison, and M. M. Hussain Retinyl ester secretion by intestinal cells: a specific and regulated process dependent on assembly and secretion of chylomicrons J. Lipid Res., February 1, 2001; 42(2): 272 - 280. [Abstract] [Full Text]

				R. W. Mahley, Y. Huang, and S. C. Rall , Jr. Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes J. Lipid Res., November 1, 1999; 40(11): 1933 - 1949. [Abstract] [Full Text]

				K. C-W. Yu, Y. Jiang, W. Chen, and A. D. Cooper Evaluation of the components of the chylomicron remnant removal mechanism by use of the isolated perfused mouse liver J. Lipid Res., October 1, 1999; 40(10): 1899 - 1910. [Abstract] [Full Text]

				C. M. Barbagallo, J. Fan, P. J. Blanche, M. Rizzo, J. M. Taylor, and R. M. Krauss Overexpression of Human Hepatic Lipase and ApoE in Transgenic Rabbits Attenuates Response to Dietary Cholesterol and Alters Lipoprotein Subclass Distributions Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 625 - 632. [Abstract] [Full Text] [PDF]

				J. R. Burnett, P. H. R. Barrett, P. Vicini, D. B. Miller, D. E. Telford, S. J. Kleinstiver, and M. W. Huff The HMG-CoA Reductase Inhibitor Atorvastatin Increases the Fractional Clearance Rate of Postprandial Triglyceride-Rich Lipoproteins in Miniature Pigs Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1906 - 1914. [Abstract] [Full Text] [PDF]

				Y. Huang, S. C. Rall Jr, and R. W. Mahley Genetic Factors Precipitating Type III Hyperlipoproteinemia in Hypolipidemic Transgenic Mice Expressing Human Apolipoprotein E2 Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2817 - 2824. [Abstract] [Full Text]

				Y. Huang, S. W. Schwendner, S. C. Rall Jr., D. A. Sanan, and R. W. Mahley Apolipoprotein E2 Transgenic Rabbits. MODULATION OF THE TYPE III HYPERLIPOPROTEINEMIC PHENOTYPE BY ESTROGEN AND OCCURRENCE OF SPONTANEOUS ATHEROSCLEROSIS J. Biol. Chem., September 5, 1997; 272(36): 22685 - 22694. [Abstract] [Full Text] [PDF]

				M. M. Hussain, I. J. Goldberg, K. H. Weisgraber, R. W. Mahley, and T. L. Innerarity Uptake of Chylomicrons by the Liver, but Not by the Bone Marrow, Is Modulated by Lipoprotein Lipase Activity Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1407 - 1413. [Abstract] [Full Text]

				S. Ishibashi, S. Perrey, Z. Chen, J.-i. Osuga, M. Shimada, K. Ohashi, K. Harada, Y. Yazaki, and N. Yamada Role of the Low Density Lipoprotein (LDL) Receptor Pathway in the Metabolism of Chylomicron Remnants. A QUANTITATIVE STUDY IN KNOCKOUT MICE LACKING THE LDL RECEPTOR, APOLIPOPROTEIN E, OR BOTH J. Biol. Chem., September 13, 1996; 271(37): 22422 - 22427. [Abstract] [Full Text] [PDF]

				J. D. Medh, S. L. Bowen, G. L. Fry, S. Ruben, M. Andracki, I. Inoue, J.-M. Lalouel, D. K. Strickland, and D. A. Chappell Lipoprotein Lipase Binds to Low Density Lipoprotein Receptors and Induces Receptor-mediated Catabolism of Very Low Density Lipoproteins in Vitro J. Biol. Chem., July 19, 1996; 271(29): 17073 - 17080. [Abstract] [Full Text] [PDF]

				D. S. Ng, C. Vezina, T. S. Wolever, A. Kuksis, R. A. Hegele, and P. W. Connelly Apolipoprotein A-I Deficiency : Biochemical and Metabolic Characteristics Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2157 - 2164. [Abstract] [Full Text]